0001607062-21-000058.txt : 20210318 0001607062-21-000058.hdr.sgml : 20210318 20210318185658 ACCESSION NUMBER: 0001607062-21-000058 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIKIS THOMAS EVANGELOS CENTRAL INDEX KEY: 0001749112 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-55657 FILM NUMBER: 21755931 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPATHIX, INC. CENTRAL INDEX KEY: 0001615999 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462645343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 858-883-2642 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 FORMER COMPANY: FORMER CONFORMED NAME: Neuropathix, Inc. DATE OF NAME CHANGE: 20201112 FORMER COMPANY: FORMER CONFORMED NAME: Kannalife Inc DATE OF NAME CHANGE: 20181113 FORMER COMPANY: FORMER CONFORMED NAME: TYG Solutions Corp. DATE OF NAME CHANGE: 20140821 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2021-03-12 2021-03-16 0 0001615999 NEUROPATHIX, INC. NPTX 0001749112 KIKIS THOMAS EVANGELOS 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 1 1 0 0 Chief Communication Officer Employee Stock Option (Right to Buy) 0.13 2021-03-12 4 A 0 800000 0 A 2031-03-11 Common Stock 800000 800000 D 1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter. This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on March 16, 2021 is being filed to correct an administrative error, resulting in the incorrect expiration date being included for the options. As reflected in this Form 4/A, the correct expiration date for the options is March 11, 2031. /s/ Thomas E. Kikis 2021-03-18